Compare VSH & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VSH | ATRC |
|---|---|---|
| Founded | 1962 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | N/A | 2005 |
| Metric | VSH | ATRC |
|---|---|---|
| Price | $15.20 | $39.86 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | $19.00 | ★ $52.00 |
| AVG Volume (30 Days) | ★ 1.8M | 537.1K |
| Earning Date | 11-05-2025 | 10-29-2025 |
| Dividend Yield | ★ 2.63% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,982,842,000.00 | $518,304,999.00 |
| Revenue This Year | $5.15 | $16.90 |
| Revenue Next Year | $6.09 | $12.29 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 15.80 |
| 52 Week Low | $10.35 | $28.29 |
| 52 Week High | $19.81 | $43.11 |
| Indicator | VSH | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 59.71 | 67.33 |
| Support Level | $13.35 | $34.88 |
| Resistance Level | $15.41 | $38.90 |
| Average True Range (ATR) | 0.60 | 1.85 |
| MACD | 0.36 | 0.58 |
| Stochastic Oscillator | 95.47 | 89.71 |
Vishay Intertechnology Inc provides a broad product portfolio of discrete semiconductors and passive electronic components to original equipment manufacturers and distributors. These products are found in industrial, computing, automotive, consumer, telecommunications, power supplies, military, aerospace, and medical markets and serve customer all over the world. Its product segments consist of two general classes: semiconductors and passive components. The company's operating segment includes metal oxide semiconductor field-effect transistors, diodes, optoelectronic components, resistors, inductors, and capacitors. Revenue mainly comes from resistors, which are basic components used in all forms of electronic circuitry to adjust and regulate levels of voltage and current.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.